Abstract LB520: A pharmacodynamic platform using liquid biopsy to support dose selection for the ATR inhibitor ART0380 (IACS-030380)Manish R. Patel, Melissa M. Johnson, Marina Roy Luzarraga et al.|Cancer Research|2022Cited by 3
Abstract CT267: First results of ART0380 (an ATR kinase inhibitor) with low dose irinotecan in advanced or metastatic solid tumorsSusanna V. Ulahannan, Babar Bashir, Jason T. Henry et al.|Cancer Research|2025Cited by 3